Volume 61, Issue 1, Pages (January 2002)

Slides:



Advertisements
Similar presentations
Volume 59, Issue 2, Pages (February 2001)
Advertisements

Eoin O’Brien, DSc, MD, Eamon Dolan, MD, FRCPI  Clinical Therapeutics 
Volume 56, Pages S238-S241 (July 1999)
Volume 57, Issue 5, Pages (May 2000)
Bias in clinical research
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Volume 62, Issue 3, Pages (September 2002)
Intensive hemodialysis—keeping the faith
Dialysate magnesium level and blood pressure
Volume 83, Issue 5, Pages (May 2013)
Volume 54, Pages S86-S91 (December 1998)
Volume 57, Issue 5, Pages (May 2000)
Prof. Silvio Cavalcanti, DEIS, Silvia Cavani, Antonio Santoro 
Volume 93, Issue 1, Pages (January 2018)
Intensive hemodialysis—keeping the faith
Volume 61, Issue 6, Pages (June 2002)
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Volume 59, Issue 1, Pages (January 2001)
M. Kraemer, C. Rode, V. Wizemann  Kidney International 
Salt and Hypertension American Journal of Kidney Diseases
Dialysate magnesium level and blood pressure
Volume 84, Issue 4, Pages (October 2013)
Volume 76, Issue 10, Pages (November 2009)
Prediction of hypertension in chronic hemodialysis patients
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients  Tatsuya Shoji, Yoshiharu Tsubakihara,
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Volume 87, Issue 2, Pages (February 2015)
Volume 66, Issue 1, Pages (July 2004)
Volume 91, Issue 5, Pages (May 2017)
Volume 74, Issue 9, Pages (November 2008)
Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions  Nikolaos Karamperis, Erik Sloth,
Blood pressure targets in hemodialysis patients
Volume 56, Issue 4, Pages (October 1999)
Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients  Denis Fouque, Susy C. Peng, Eshan Shamir, Joel.
Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow  Steve J. Schwab, Matthew J. Oliver,
Effects of hemodialysis on cardiac function
Volume 62, Issue 5, Pages (November 2002)
Volume 61, Issue 6, Pages (June 2002)
SYMPLICITY: not all that simple
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Volume 62, Issue 3, Pages (September 2002)
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
The role of daily dialysis in the control of hyperphosphatemia
Volume 61, Issue 1, Pages (January 2002)
Volume 79, Issue 2, Pages (January 2011)
Volume 81, Issue 4, Pages (February 2012)
Volume 54, Pages S135-S139 (December 1998)
Volume 73, Issue 8, Pages (April 2008)
Volume 62, Pages S47-S52 (December 2002)
Volume 58, Issue 1, Pages (July 2000)
Volume 58, Issue 5, Pages (November 2000)
Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction  Adam G. McLean, Andrew Davenport, Dominic.
Volume 62, Issue 3, Pages (September 2002)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Hemodialysis with high-calcium dialysate impairs cardiac relaxation
The course of the remnant kidney model in mice
Volume 95, Issue 6, Pages (June 2019)
Volume 60, Issue 3, Pages (September 2001)
Volume 56, Pages S238-S241 (July 1999)
Clinical and biochemical correlates of starting “daily” hemodialysis
Volume 75, Issue 1, Pages (January 2009)
Importance of blood pressure control in hemodialysis patient survival
Volume 68, Issue 1, Pages (July 2005)
Volume 59, Issue 2, Pages (February 2001)
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Rebound kinetics of β2-microglobulin after hemodialysis
Longitudinal relationships between diet-dependent renal acid load and blood pressure development in healthy children  Danika Krupp, Lijie Shi, Thomas.
Antonio Piccoli, Luana Pillon  Kidney International 
Presentation transcript:

Volume 61, Issue 1, Pages 276-287 (January 2002) Dialysate calcium profiling during hemodialysis: Use and clinical implications  John Kyriazis, M.D., John Glotsos, Leonidas Bilirakis, Nikos Smirnioudis, Maria Tripolitou, Fotios Georgiakodis, Irene Grimani  Kidney International  Volume 61, Issue 1, Pages 276-287 (January 2002) DOI: 10.1046/j.1523-1755.2002.00100.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Changes in serum ionized calcium (iCa) during hemodialysis. Symbols are: (•) dialysate calcium profiling (dCaP), (▪) low (1.25 mmol/L) dialysate calcium (LdCa), (▴) medium (1.5 mmol/L) dialysate calcium (MdCa); (*) a significant difference between dCaP group and both LdCa and MdCa groups; (**) a significant difference between MdCa and LdCa groups; (+) a significant difference between MdCa group and both LdCa and dCaP groups. Data points represent mean values ± SD. Kidney International 2002 61, 276-287DOI: (10.1046/j.1523-1755.2002.00100.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Hourly intradialytic percent changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and cardiac index (CI). Symbols are: (•) dialysate calcium profiling (dCaP); (▪) low (1.25 mmol/L) dialysate calcium (LdCa); (▴) medium (1.5 mmol/L) dialysate calcium (MdCa); (*) significant difference between dCaP group and both LdCa and MdCa groups. Data points represent mean values ± SEM. (Study A, N = 18). Kidney International 2002 61, 276-287DOI: (10.1046/j.1523-1755.2002.00100.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) during hemodialysis. Symbols are: (•) dialysate calcium profiling (dCaP); (▪) low (1.25 mmol/L) dialysate calcium (LdCa); (▴) medium (1.5 mmol/L) dialysate calcium (MdCa). The numbers above horizontal arrows are the mean changes in blood pressure during the first half (0 to 2 hours) and second half (2 to 4 hours) of a four-hour HD session. Vertical arrows indicate the mean differences in blood pressure between the three treatment groups at the end of HD, which are presented in the left lower part of each graph. The corresponding mean differences in the middle of HD were not statistically significant and pertaining data are not shown. The 95% level confidence interval for the means is given in parentheses. Unidirectional arrows are used for simplicity, although the order in which participants were given the dCa treatments was random with a crossover design. *P < 0.05, **P < 0.01, ***P < 0.001. Kidney International 2002 61, 276-287DOI: (10.1046/j.1523-1755.2002.00100.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Changes in cardiac index (CI) and stroke index (SI) during hemodialysis. Symbols are: (•) dialysate calcium profiling (dCaP); (▪) low (1.25 mmol/L) dialysate calcium (LdCa); (▴) medium (1.5 mmol/L) dialysate calcium (MdCa). The numbers above horizontal arrows are the mean changes in cardiac indices during the first half (0 to 2 hours) and second half (2 to 4 hours) of a four-hour HD session. Vertical arrows indicate the mean differences in cardiac indices between the three treatment groups at the end of HD, which are presented in the left lower part of each graph. The corresponding mean differences in the middle of HD were not statistically significant and pertaining data are not shown. The 95% confidence interval for the means is given in parentheses. Unidirectional arrows are used for simplicity, although the order in which participants were given the dCa treatments was random with a crossover design. *P < 0.05, **P < 0.01, ***P < 0.001. Kidney International 2002 61, 276-287DOI: (10.1046/j.1523-1755.2002.00100.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Hourly intradialytic percent changes in systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP). Symbols are: (•) dialysate calcium profiling (dCaP); (▪) low (1.25 mmol/L) dialysate calcium (LdCa); (▴) medium (1.5 mmol/L) dialysate calcium (MdCa); (*) significant difference between dCaP group and both LdCa and MdCa groups; (+) significant difference between dCaP and LdCa groups. Data points represent mean values ± SEM (Study B, N = 8). Kidney International 2002 61, 276-287DOI: (10.1046/j.1523-1755.2002.00100.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Hourly intradialytic percent changes in MAP in non-responders (A) and responders (B). See text for details. Symbols are: (•) dialysate calcium profiling (dCaP); (▪) low (1.25 mmol/L) dialysate calcium (LdCa); (▴) medium (1.5 mmol/L) dialysate calcium (MdCa); (*) statistically significant difference between dCaP group and both LdCa and MdCa groups. Data points represent mean values ± SEM. Kidney International 2002 61, 276-287DOI: (10.1046/j.1523-1755.2002.00100.x) Copyright © 2002 International Society of Nephrology Terms and Conditions